Qiagen, a Netherlands-based leading global provider of Sample to Insight solutions, announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more ...

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system ...

Multiplexed pathogen detection is pivotal for the simultaneous identification of multiple nucleic acid targets in clinical diagnostics. Fluorescent reporters are widely employed for real-time ...

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples January 10, 2025 QIAcuity digital PCR now offers ability for simultaneous ...

As the need for more sensitive and precise molecular quantification grows across translational research, diagnostics, and therapeutic development, conventional PCR workflows can fall short. Detecting ...

In the dynamic biotechnology and biopharmaceutical science fields, qPCR and dPCR multiplexing has emerged as a crucial technique for accelerated and consistent research workflows. Multiplexed ...

An overview of the MP4 screening assay is presented in Fig. 1. Saliva, collected in barcoded tubes across campus (Supplementary Fig. s1), was brought to the lab by couriers and immediately placed in a ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold increase from prior capability ...

Alex Zevin, PhD, began serving as the director of the Genomics Shared Resource at Fred Hutch in December 2022. Before that, he was a research scientist at ArcherDX where he developed NGS in vitro ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By ...